The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Nature Medicine Année : 2022

The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration

1 ITX-lab - ITX-lab unité de recherche de l'institut du thorax UMR1087 UMR6291
2 SPHERE - MethodS in Patients-centered outcomes and HEalth ResEarch
3 TAU - Tel Aviv University
4 BWH - Brigham & Women’s Hospital [Boston]
5 Unipd - Università degli Studi di Padova = University of Padua
6 UAB - Universitat Autònoma de Barcelona = Autonomous University of Barcelona = Universidad Autónoma de Barcelona
7 Vall d'Hebron University Hospital [Barcelona]
8 UNIMIB - Università degli Studi di Milano-Bicocca = University of Milano-Bicocca
9 IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico
10 Llobregat Hospital [Barcelona]
11 Fondazione Avantea [Cremona, Italy]
12 St. Boniface Hospital Albrechtsen Research Centre [Winnipeg]
13 IIBR - Israel Institute for Biological Research
14 UC Davis - University of California [Davis]
15 IDIBELL - Institut d'Investigació Biomèdica de Bellvitge = Bellvitge Biomedical Research Institute
16 QTHI - Quironsalud Teknon Heart Institute [Barcelona, Spain]
17 Mind the Byte [Barcelona, Spain]
18 Molomics [Barcelona, Spain]
19 Sahlgrenska Academy at University of Gothenburg [Göteborg]
20 (Inkemia Group) IUCT - Institut Universitari de Ciència i Tecnologia [Barcelona, Spain]
21 DH - DevsHealth [Barcelona, Spain]
22 UCL - University College of London [London]
23 Bellvitge University Hospital = Bellvitge Hospital Universitari
24 U1064 Inserm - CR2TI - Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology
Salam Bashir
  • Fonction : Auteur
Cristina Costa
Galli Cesare
Alejandro Ruiz-Majoral
Liana Govani
  • Fonction : Auteur
Sharon Yehuda
Ron Amon
  • Fonction : Auteur
Hai Yu
Xi Chen
Vered Padler-Karavani
  • Fonction : Auteur correspondant
  • PersonId : 1107085

Connectez-vous pour contacter l'auteur

Résumé

Abstract Bioprosthetic heart valves (BHVs) are commonly used to replace severely diseased heart valves but their susceptibility to structural valve degeneration (SVD) limits their use in young patients. We hypothesized that antibodies against immunogenic glycans present on BHVs, particularly antibodies against the xenoantigens galactose-α1,3-galactose (αGal) and N -glycolylneuraminic acid (Neu5Gc), could mediate their deterioration through calcification. We established a large longitudinal prospective international cohort of patients ( n = 1668, 34 ± 43 months of follow-up (0.1–182); 4,998 blood samples) to investigate the hemodynamics and immune responses associated with BHVs up to 15 years after aortic valve replacement. Early signs of SVD appeared in <5% of BHV recipients within 2 years. The levels of both anti-αGal and anti-Neu5Gc IgGs significantly increased one month after BHV implantation. The levels of these IgGs declined thereafter but anti-αGal IgG levels declined significantly faster in control patients compared to BHV recipients. Neu5Gc, anti-Neu5Gc IgG and complement deposition were found in calcified BHVs at much higher levels than in calcified native aortic valves. Moreover, in mice, anti-Neu5Gc antibodies were unable to promote calcium deposition on subcutaneously implanted BHV tissue engineered to lack αGal and Neu5Gc antigens. These results indicate that BHVs manufactured using donor tissues deficient in αGal and Neu5Gc could be less prone to immune-mediated deterioration and have improved durability.
Fichier principal
Vignette du fichier
s41591-022-01682-w.pdf (5.83 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03580771 , version 1 (18-02-2022)

Identifiants

Citer

Thomas Senage, Anu Paul, Thierry Le Tourneau, Imen Fellah-Hebia, Marta Vadori, et al.. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nature Medicine, 2022, Online ahead of print. ⟨10.1038/s41591-022-01682-w⟩. ⟨inserm-03580771⟩
42 Consultations
41 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More